CELEBREX: THE FIRST SPECIFIC INHIBITOR OF COX-2: NEW DATA

類似資料

• CELEBREX-A SPECIFIC INHIBITOR OF CYCLOOXIGENASE-2: EFFICACY AND TOLERABILITY
  著者:: - -
  出版事項: (2000-04-01)
• What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex)
  著者:: Wooltorton, Eric
  出版事項: (2002)
• A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study
  著者:: Rogers Elaine S, 等
  出版事項: (2011-11-01)
• A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study
  著者:: Rogers, Elaine S, 等
  出版事項: (2011)
• Celebrex in treatment of joint diseases in patients with risk factors of gastropathy and cardiovascular palhalodydevelopment
  著者:: N. V. Chichasova, 等
  出版事項: (2004-02-01)